{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:29:51Z","timestamp":1793298591848,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004080","name":"Korea Drug Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004080","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2021-DD120874"],"award-info":[{"award-number":["RS-2021-DD120874"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HN21C0984"],"award-info":[{"award-number":["HN21C0984"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002641","name":"Konkuk University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002530","name":"Kyungnam University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.bioorg.2024.107481","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T11:19:57Z","timestamp":1716290397000},"page":"107481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of 2-(2-oxoindolin-3-ylidene)hydrazinecarbothioamides as a potential EGR-1 inhibitor for targeted therapy of atopic dermatitis"],"prefix":"10.1016","volume":"148","author":[{"given":"Seunghyun","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjin","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euitaek","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngshim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsoo","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeonhwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Han Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoongho","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon","family":"Young Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bioorg.2024.107481_b0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjd.19580","article-title":"The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990\u20132017","volume":"184","author":"Laughter","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bioorg.2024.107481_b0010","first-page":"81","article-title":"Atopic dermatitis\/atopic eczema, History of","volume":"100","author":"Wallach","year":"2014","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107481_b0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/healthcare8020070","article-title":"Atopic Dermatitis and Comorbidity","volume":"8","author":"Bekic","year":"2020","journal-title":"Healthcare (basel)"},{"issue":"10023","key":"10.1016\/j.bioorg.2024.107481_b0020","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107481_b0025","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1365-2230.2000.00698.x","article-title":"Epidemiology of atopic dermatitis","volume":"25","author":"Williams","year":"2000","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107481_b0030","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: Receptors, functions, and roles in diseases","volume":"138","author":"Akdis","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bioorg.2024.107481_b0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coi.2018.05.005","article-title":"Cytokine modulation of atopic itch","volume":"54","author":"Trier","year":"2018","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107481_b0040","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0952-7915(01)00287-4","article-title":"T-cell subpopulations in the development of atopic and contact allergy","volume":"13","author":"Girolomoni","year":"2001","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107481_b0045","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI124606","article-title":"Epithelial cell\u2013derived cytokines: more than just signaling the alarm","volume":"129","author":"Roan","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107481_b0050","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.det.2017.02.005","article-title":"The role of interleukins 4 and\/or 13 in the pathophysiology and treatment of atopic dermatitis","volume":"35","author":"Silverberg","year":"2017","journal-title":"Dermatol. Clin."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107481_b0055","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1046\/j.0022-202x.2001.01484.x","article-title":"Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis","volume":"117","author":"Chan","year":"2001","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107481_b0060","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/jid.2008.295","article-title":"Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling","volume":"129","author":"Zheng","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107481_b0065","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","article-title":"A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1","volume":"133","author":"Cevikbas","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107481_b0070","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1111\/all.14791","article-title":"Interleukin-31: The \u201citchy\u201d cytokine in inflammation and therapy","volume":"76","author":"Datsi","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.bioorg.2024.107481_b0075","unstructured":"J.-I. Pagel, E. Deindl, Early growth response 1\u2014a transcription factor in the crossfire of signal transduction cascades, (2011)."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107481_b0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12032-019-1333-6","article-title":"Friend or foe, the role of EGR-1 in cancer","volume":"37","author":"Li","year":"2019","journal-title":"Med Oncol"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107481_b0085","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1074\/jbc.M506770200","article-title":"Role of early growth response-1 (Egr-1) in interleukin-13-induced inflammation and remodeling","volume":"281","author":"Cho","year":"2006","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107481_b0090","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bbrc.2008.07.117","article-title":"Regulatory mechanism of TNFalpha autoregulation in HaCaT cells: the role of the transcription factor EGR-1","volume":"374","author":"Son","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107481_b0095","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/82168","article-title":"Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress","volume":"6","author":"Yan","year":"2000","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107481_b0100","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bbagrm.2013.07.005","article-title":"Transcriptional regulation of the growth-regulated oncogene alpha gene by early growth response protein-1 in response to tumor necrosis factor alpha stimulation","volume":"1829","author":"Shin","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"10.1016\/j.bioorg.2024.107481_b0105","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1089\/104303400750001444","article-title":"Tissue repair with a therapeutic transcription factor","volume":"11","author":"Bryant","year":"2000","journal-title":"Hum Gene Ther"},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2024.107481_b0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11568-007-9010-9","article-title":"Evidence of EGR1 as a differentially expressed gene among proliferative skin diseases","volume":"1","author":"Fang","year":"2007","journal-title":"Genomic Med"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107481_b0115","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jid.2020.12.029","article-title":"Disrupting the DNA binding of EGR-1 with a small-molecule inhibitor ameliorates 2, 4-dinitrochlorobenzene-induced skin inflammation","volume":"141","author":"Yeo","year":"2021","journal-title":"J. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107481_b0120","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/exd.12788","article-title":"IL-33 induces Egr-1-dependent TSLP expression via the MAPK pathways in human keratinocytes","volume":"24","author":"Ryu","year":"2015","journal-title":"Exp Dermatol"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107481_b0125","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/exd.12554","article-title":"Egr-1 is a key regulator of IL-17A-induced psoriasin upregulation in psoriasis","volume":"23","author":"Jeong","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.bioorg.2024.107481_b0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bbrc.2020.11.089","article-title":"EGR-1 acts as a transcriptional activator of KLK7 under IL-13 stimulation","volume":"534","author":"Yeo","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107481_b0135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s13765-014-4163-4","article-title":"Conversion of flavonoids and their conformation by NMR and DFT","volume":"57","author":"Yong","year":"2014","journal-title":"J Korean Soc Appl Bi"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107481_b0140","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1016\/j.ejmech.2010.09.060","article-title":"Synthesis and antibacterial activity of C-12 pyrazolinyl spiro ketolides","volume":"45","author":"Hu","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107481_b0145","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.ejmech.2008.09.032","article-title":"Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity","volume":"44","author":"Havrylyuk","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107481_b0150","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1007\/s00044-011-9912-x","article-title":"Anti-HIV-1 and cytotoxicity studies of piperidyl-thienyl chalcones and their 2-pyrazoline derivatives","volume":"21","author":"Rizvi","year":"2012","journal-title":"Med. Chem. Res."},{"issue":"9","key":"10.1016\/j.bioorg.2024.107481_b0155","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1016\/j.ejmech.2011.07.007","article-title":"One-pot synthesis of pyrazoline derivatised carbazoles as antitubercular, anticancer agents, their DNA cleavage and antioxidant activities","volume":"46","author":"Taj","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2024.107481_b0160","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1021\/jm100505n","article-title":"Discovery of (3 S, 3a R)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3, 3a, 4, 5-tetrahydro-2 H-benzo [g] indazole-7-carboxylic Acid (PF-3882845), an Orally Efficacious Mineralocorticoid Receptor (MR) Antagonist for Hypertension and Nephropathy","volume":"53","author":"Meyers","year":"2010","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107481_b0165","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1016\/j.ejmech.2010.10.005","article-title":"Synthesis and biological evaluation of N-substituted-3, 5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors","volume":"45","author":"Fioravanti","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2024.107481_b0170","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ejmech.2007.11.029","article-title":"Synthesis and biological evaluation of pyrazoline analogues with \u03b2-amino acyl group as dipeptidyl peptidase IV inhibitors","volume":"43","author":"Jun","year":"2008","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107481_b0175","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/mrc.4367","article-title":"(1) H and (13) C NMR spectral assignments of 19 novel polymethoxylated diphenylnaphthylpyrazolinylcarbothioamides","volume":"54","author":"Jung","year":"2016","journal-title":"Magn Reson Chem"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107481_b0180","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.ejmech.2008.09.020","article-title":"Synthesis and pharmacological evaluation of a novel series of 5-(substituted) aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines as novel anti-inflammatory and analgesic agents","volume":"44","author":"Khode","year":"2009","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107481_b0185","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ardp.200800130","article-title":"Design, Synthesis, and In-Vivo Pharmacological Screening of N, 3-(Substituted Diphenyl)-5-phenyl-1H-pyrazoline-1-carbothioamide Derivatives","volume":"342","author":"Siddiqui","year":"2009","journal-title":"Archiv Der Pharmazie: an International Journal Pharmaceutical and Medicinal Chemistry"},{"issue":"24","key":"10.1016\/j.bioorg.2024.107481_b0190","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1016\/j.bmcl.2008.10.084","article-title":"Pyrazoline-based mycobactin analogues as MAO-inhibitors","volume":"18","author":"Jayaprakash","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107481_b0195","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1021\/ml2001196","article-title":"Optimization of the Central Core of Indolinone-Acetic Acid-Based CRTH2 (DP2) Receptor Antagonists","volume":"2","author":"Crosignani","year":"2011","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bioorg.2024.107481_b0200","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ejmech.2016.08.011","article-title":"Oxindole: A chemical prism carrying plethora of therapeutic benefits","volume":"123","author":"Kaur","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2024.107481_b0205","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2174\/1389557516666160624125108","article-title":"Spirooxindoles as Potential Pharmacophores","volume":"17","author":"Panda","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107481_b0210","doi-asserted-by":"crossref","first-page":"14959","DOI":"10.3390\/molecules200814959","article-title":"Inhibitory Activity of Yokukansankachimpihange against Nerve Growth Factor-Induced Neurite Growth in Cultured Rat Dorsal Root Ganglion Neurons","volume":"20","author":"Murayama","year":"2015","journal-title":"Molecules"},{"issue":"D1","key":"10.1016\/j.bioorg.2024.107481_b0215","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"20","key":"10.1016\/j.bioorg.2024.107481_b0220","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1101\/gad.250746.114","article-title":"Wilms tumor protein recognizes 5-carboxylcytosine within a specific DNA sequence","volume":"28","author":"Hashimoto","year":"2014","journal-title":"Genes Dev"},{"issue":"26","key":"10.1016\/j.bioorg.2024.107481_b0225","doi-asserted-by":"crossref","first-page":"E1724","DOI":"10.1073\/pnas.1121500109","article-title":"Asymmetrical roles of zinc fingers in dynamic DNA-scanning process by the inducible transcription factor Egr-1","volume":"109","author":"Zandarashvili","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107481_b0230","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/j.jid.2022.03.021","article-title":"Transcription factor EGR1 regulates the expression of the clock gene PER2 under IL-4 stimulation in human keratinocytes","volume":"142","author":"Yeo","year":"2022","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.bioorg.2024.107481_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2024.01.017","article-title":"The EGR1-ARTN axis in keratinocytes enhances the innervation of epidermal sensory neurons during skin inflammation induced by house dust mite extract from Dermatophagoides farinae","author":"Yeo","year":"2024","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.bioorg.2024.107481_b0240","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107481_b0245","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/1523-1747.ep12325538","article-title":"Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice","volume":"105","author":"Kitagaki","year":"1995","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107481_b0250","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/bjd.14871","article-title":"Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial","volume":"175","author":"Bissonnette","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107481_b0255","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1038\/jid.2013.250","article-title":"Mast cells are required for full expression of allergen\/SEB-induced skin inflammation","volume":"133","author":"Ando","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107481_b0260","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.20051745","article-title":"Thymic stromal lymphopoietin: master switch for allergic inflammation","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bioorg.2024.107481_b0265","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.immunol.25.022106.141718","article-title":"TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation","volume":"25","author":"Liu","year":"2007","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107481_b0270","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ni.1852","article-title":"Sensing the outside world: TSLP regulates barrier immunity","volume":"11","author":"Ziegler","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bioorg.2024.107481_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107648","article-title":"TSLP as druggable target - a silver-lining for atopic diseases?","volume":"217","author":"Adhikary","year":"2021","journal-title":"Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.bioorg.2024.107481_b0280","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archderm.139.11.1455","article-title":"Neuronal sensitization for histamine-induced itch in lesional skin of patients with atopic dermatitis","volume":"139","author":"Ikoma","year":"2003","journal-title":"Arch. Dermatol."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107481_b0285","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/1346-8138.12317","article-title":"Itch and nerve fibers with special reference to atopic dermatitis: therapeutic implications","volume":"41","author":"Tominaga","year":"2014","journal-title":"J. Dermatol."},{"key":"10.1016\/j.bioorg.2024.107481_b0290","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00403-012-1246-0","article-title":"PGP 9.5 distribution patterns in biopsies from early lesions of atopic dermatitis","volume":"304","author":"Emtestam","year":"2012","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.bioorg.2024.107481_b0295","first-page":"7489316","article-title":"UCHL1\/PGP 9.5 dynamic in neuro-immune-cutaneous milieu: focusing on axonal nerve terminals and epidermal keratinocytes in psoriatic itch","author":"Kupczyk","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107481_b0300","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/mrc.5113","article-title":"1H and 13C NMR spectral assignment of 29 N\u2032-(3-([1, 1\u2032-biphenyl]-4-yl)-1-phenyl-1H-pyrazol-4-yl) acylhydrazones","volume":"59","author":"Park","year":"2021","journal-title":"Magn. Reson. Chem."},{"issue":"42","key":"10.1016\/j.bioorg.2024.107481_b0305","doi-asserted-by":"crossref","first-page":"11140","DOI":"10.1002\/anie.201405820","article-title":"History of the Harvard ChemDraw project","volume":"53","author":"Evans","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107481_b0310","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"13","key":"10.1016\/j.bioorg.2024.107481_b0315","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2024.107481_b0320","series-title":"LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery","author":"Laskowski","year":"2011"},{"key":"10.1016\/j.bioorg.2024.107481_b0325","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biopha.2017.03.065","article-title":"Cynanchum atratum inhibits the development of atopic dermatitis in 2,4-dinitrochlorobenzene-induced mice","volume":"90","author":"Choi","year":"2017","journal-title":"Biomed Pharmacother"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824003869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824003869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T15:17:20Z","timestamp":1717600640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824003869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":65,"alternative-id":["S0045206824003869"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107481","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of 2-(2-oxoindolin-3-ylidene)hydrazinecarbothioamides as a potential EGR-1 inhibitor for targeted therapy of atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107481"}}